Heparin enhances the furin cleavage of HIV-1 gp160 peptides

被引：22

作者：

Pasquato, A. ^{[1
,2
]}

Dettin, M. ^{[2
]}

Basak, A. ^{[3
]}

Gambaretto, R. ^{[2
]}

Tonin, L. ^{[2
]}

Seidah, N. G. ^{[1
]}

Di Bello, C. ^{[2
]}

机构：

[1] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada

[2] Univ Padua, Dept Chem Proc Engn, I-35131 Padua, Italy

[3] Ottawa Hlth Res Inst, Dis Aging Program, Reg Protein Chem Ctr, Ottawa, ON K1Y 4E9, Canada

来源：

FEBS LETTERS | 2007年 / 581卷 / 30期

基金：

加拿大健康研究院;

关键词：

HIV-1; furin; heparin; glycosaminoglycan; gp160; processing;

D O I：

10.1016/j.febslet.2007.11.050

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Infectious HIV-1 requires gp160 cleavage by furin at the REKR511 down arrow motif (site1) into the gp120/gp41 complex, whereas the KAKR(503) (site2) sequence remains uncleaved. We synthesized 41mer and 51mer peptides, comprising site1 and site2, to study their conformation and in vitro furin processing. We found that, while the previously reported 19mer and 13mer analogues represent excellent in vitro furin substrates, the present extended sequences require heparin for optimal processing. Our data support the hypothesis of a direct binding of heparin with site1 and site2, allowing selective exposure/accessibility of the REKR sequence, which is only then optimally cleaved by furin. (C) 2007 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

引用

页码：5807 / 5813

页数：7

共 50 条

[41] FUNCTIONAL ROLES OF THE V3 HYPERVARIABLE REGION OF HIV-1 GP160 IN THE PROCESSING OF GP160 AND IN THE FORMATION OF SYNCYTIA IN CD4+ CELLS
TRAVIS, BM
DYKERS, TI
HEWGILL, D
LEDBETTER, J
TSU, TT
HU, SL
LEWIS, JB
VIROLOGY, 1992, 186 (01) : 313 - 317
[42] REAL-TIME BIOSPECIFIC INTERACTION ANALYSIS OF ANTIBODY REACTIVITY TO PEPTIDES FROM THE ENVELOPE GLYCOPROTEIN, GP160, OF HIV-1
VANCOTT, TC
LOOMIS, LD
REDFIELD, RR
BIRX, DL
JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 146 (02) : 163 - 176
[43] Furin cleavage of the HIV-1 tat protein
Tikhonov, I
Ruckwardt, TJ
Berg, S
Hatfield, GS
Pauza, CD
FEBS LETTERS, 2004, 565 (1-3) : 89 - 92
[44] Immunogenicity of HIV-1(LAI) gp160 and env peptides in squirrel monkey Saimiri sciureus using alumine and experimental adjuvants
Perraut, R
Chouteau, P
Moog, C
Bonnemains, B
Kieny, MP
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 106 (03): : 434 - 441
[45] Prediction of VRC01 Neutralization Sensitivity by HIV-1 gp160 Sequence Features
Magaret, Craig A.
Williamson, Brian D.
Borate, Bhavesh
Carpp, Lindsay
Georgiev, Ivelin
Setliff, Ian
Dingens, Adam S.
Benkesser, David C.
Simon, Noah
Carone, Marco
Montefiori, David
Alter, Galit
Yu, Wen-Han
Juraska, Michal
Edlefsen, Paul T.
Karuna, Shelly
Mgodi, Nyaradzo M.
Edugupanti, Srilatha
Gilbert, Peter B.
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 344 - 344
[46] Inhibition of HIV-1 infection by an intramolecular antisense peptide to T20 in gp160
Imai, M
Okada, N
Okada, H
MICROBIOLOGY AND IMMUNOLOGY, 2000, 44 (03) : 205 - 212
[47] Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis
Micoli, KJ
Pan, G
Wu, Y
Williams, JP
Cook, WJ
McDonald, JM
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (02) : 1233 - 1240
[48] HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1) GP160-SPECIFIC LYMPHOCYTE PROLIFERATIVE RESPONSES OF MONONUCLEAR LEUKOCYTES FROM HIV-1 RECOMBINANT GP160 VACCINE RECIPIENTS
KEEFER, MC
BONNEZ, W
ROBERTS, NJ
DOLIN, R
REICHMAN, RC
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (03): : 448 - 453
[49] Comparative functional role of PC7 and furin in the processing of the HIV envelope glycoprotein gp160
Decroly, E
Benjannet, S
Savaria, D
Seidah, NG
FEBS LETTERS, 1997, 405 (01) : 68 - 72
[50] Illustrating the correlations between protein dynamics and glycan shielding of HIV-1 Env gp160
Suresh, Raghavendran
Mani, Natesan
Chakraborty, Srirupa
BIOPHYSICAL JOURNAL, 2023, 122 (03) : 189A - 189A

← 1 2 3 4 5 →